Literature DB >> 15786712

Leupaxin binds to PEST domain tyrosine phosphatase PEP.

Noriyuki Watanabe1, Natsuko Amano, Hajime Ishizuka, Keisuke Mashima.   

Abstract

PEST domain tyrosine phosphatase (PEP) is an intracellular protein tyrosine phosphatase and characterized by PEST motifs and proline-rich domains in the carboxyl terminal half. PEP is primarily expressed in hematopoietic cells, and together with PEP-binding Csk, may act as a negative regulator of antigen receptor signaling in lymphocytes. Here, we show the binding capability of PEP for leupaxin, which is preferentially expressed in hematopoietic cells and a comparatively new member of the paxillin family characterized by two protein-protein interaction modules, LIM domains and LD motifs. These results suggested that leupaxin might participate in the regulation of the signaling cascade through the binding to PEP in lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15786712     DOI: 10.1007/s11010-005-2149-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  9 in total

1.  Intact LIM 3 and LIM 4 domains of paxillin are required for the association to a novel polyproline region (Pro 2) of protein-tyrosine phosphatase-PEST.

Authors:  J F Côté; C E Turner; M L Tremblay
Journal:  J Biol Chem       Date:  1999-07-16       Impact factor: 5.157

2.  Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP.

Authors:  A Gjörloff-Wingren; M Saxena; S Williams; D Hammi; T Mustelin
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

3.  Characterization of hematopoietic intracellular protein tyrosine phosphatases: description of a phosphatase containing an SH2 domain and another enriched in proline-, glutamic acid-, serine-, and threonine-rich sequences.

Authors:  R J Matthews; D B Bowne; E Flores; M L Thomas
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

4.  Leupaxin is a novel LIM domain protein that forms a complex with PYK2.

Authors:  B P Lipsky; C R Beals; D E Staunton
Journal:  J Biol Chem       Date:  1998-05-08       Impact factor: 5.157

5.  Leupaxin is a critical adaptor protein in the adhesion zone of the osteoclast.

Authors:  Anandarup Gupta; Beth S Lee; Mohammed A Khadeer; Zhihui Tang; Meenakshi Chellaiah; Yousef Abu-Amer; Joshua Goldknopf; Keith A Hruska
Journal:  J Bone Miner Res       Date:  2003-04       Impact factor: 6.741

6.  Requirement of PEST domain tyrosine phosphatase PEP in B cell antigen receptor-induced growth arrest and apoptosis.

Authors:  K Hasegawa; H Yajima; T Katagiri; M Ogimoto; Y Arimura; K Mitomo; K Mashima; K Mizuno; H Yakura
Journal:  Eur J Immunol       Date:  1999-03       Impact factor: 5.532

7.  Hic-5, a paxillin homologue, binds to the protein-tyrosine phosphatase PEST (PTP-PEST) through its LIM 3 domain.

Authors:  N Nishiya; Y Iwabuchi; M Shibanuma; J F Côté; M L Tremblay; K Nose
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

8.  Characterization of the TGF beta 1-inducible hic-5 gene that encodes a putative novel zinc finger protein and its possible involvement in cellular senescence.

Authors:  M Shibanuma; J Mashimo; T Kuroki; K Nose
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

9.  Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase.

Authors:  J F Cloutier; A Veillette
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

  9 in total
  3 in total

1.  [Small interfering RNA-mediated LPXN silencing suppresses proliferation and enhances drug sensitivity of human acute monocytic leukemia SHI-1 cells in vitro].

Authors:  Guohua Zhu; Haiping Dai; Yuanxun Duan; Zelin Yu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-07-30

2.  Leupaxin stimulates adhesion and migration of prostate cancer cells through modulation of the phosphorylation status of the actin-binding protein caldesmon.

Authors:  Sascha Dierks; Sandra von Hardenberg; Thomas Schmidt; Felix Bremmer; Peter Burfeind; Silke Kaulfuß
Journal:  Oncotarget       Date:  2015-05-30

3.  Leupaxin Expression Is Dispensable for B Cell Immune Responses.

Authors:  Amélie Bonaud; Simon Clare; Valeria Bisio; John M Sowerby; Shugang Yao; Hanne Ostergaard; Karl Balabanian; Kenneth G C Smith; Marion Espéli
Journal:  Front Immunol       Date:  2020-03-25       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.